FROST Clinical Study

Freezing Alone Instead of Resection of Small Breast Tumors: A Study of Cryoablation in the Management of Early Stage Breast Cancer (FROST).

Sanarus Technologies is sponsoring a multi-center clinical study to treat breast cancer in those who prefer an alternative to surgery.

Participants must have the following:

  • Age: 50 and older
  • A cancer that is ≤1.5cm in its greatest diameter
  • A cancer that has not spread to other organs
  • A cancer that is strongly sensitive to estrogen
  • No prior treatment of the current breast cancer

If you would like more information, please contact us.

You can also find additional information about FROST Clinical Study on clinicaltrials.gov